Dried Plum
OtherThree doses of dried plum (0 g, 50 g and 100g) were used as intervention.
NCT Number: NCT02325895
The objective of the investigators current study was to examine whether 50 g dried plum would be as effective as 100 g dried plum in reversing bone loss in osteopenic older postmenopausal women.
Looking for future studies?
Notify Me65 year–79 year
Female
Interventional
Not applicable
Forty-five randomly assigned into one of three treatment groups: 1) 50g dried plum; 2) 100g dried plum; and 3) control (0g dried plum). All groups received 500mg calcium and 400 IU vitamin D as a daily supplement. Blood samples were collected at baseline, 3 and 6 months to assess biomarkers of bone turnover. Physical activity recall and 3-day food records were obtained at baseline, 3 and 6 months to examine physical activity and dietary confounders as potential covariates
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Three doses of dried plum (0 g, 50 g and 100g) were used as intervention.
Time frame: 6 months
Time frame: baseline, 3 months and 6 months
San Diego State University
Other
Effect of Dried Plum on Bone and Bone Biomarkers in Older Women
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06668090
Bone Diseases, Bone Diseases, Metabolic
Aarhus N, Denmark
View Trial DetailsNCT04093856
Body Weight, Bone Diseases
Montreal, Quebec, Canada
View Trial DetailsNCT01507662
Bone Diseases, Bone Diseases, Metabolic
Birmingham, Alabama, United States
View Trial DetailsNCT01360099
Bone Diseases, Bone Diseases, Metabolic
Washington D.C., District of Columbia, United States
View Trial Details